Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of SKL15508 in…
-
CLINICAL_TRIALS withdrawal · 2016-10-13Clinical Trial Update: Antipsychotic Discontinuation in High-risk Subjects
A clinical trial evaluating antipsychotic discontinuation in high-risk individuals with schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Validating Three Common Occupational Therapy Assessments in Participants With Schizophrenia
A completed clinical trial evaluating and validating three common occupational therapy assessments in participants with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia [Phase 3]
A Phase 3 trial evaluating an FDA-approved drug as add-on therapy for schizophrenia has completed.
-
FDA approval · 2016-10-07FDA Approved: ARIPIPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Macleods Pharmaceuticals Limited's generic aripiprazole (ANDA 204111) based on its original application.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-10-06FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) from H2-Pharma LLC.
-
FDA approval · 2016-10-06FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) by Eli Lilly and Company to support the intramuscular for…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia [NA]
This document reports a completed pilot trial evaluating naltrexone for obesity in women with schizophrenia; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia [NA]
This document provides an update on a clinical trial evaluating bifrontal and bitemporal electroconvulsive therapy for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia [Phase 1]
Phase 1 study evaluating roflumilast in combination with antipsychotics in schizophrenia; results from the proof-of-mechanism trial have bee…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia [NA]
A randomized clinical trial evaluating intensive computer-based cognitive remediation for recent-onset schizophrenia has completed.
-
FDA approval · 2016-09-29FDA Approved: ARIPIPRAZOLE — Original Application (Dr.Reddys Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' generic aripiprazole under an original ANDA application. This action provides a generic option for th…
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia [NA]
An ongoing clinical trial is evaluating folic acid and vitamin B12 as potential interventions for schizophrenia. The update does not provide…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Smoking Relapse Prevention in Schizophrenia [Phase 4]
This clinical trial update reports a Phase 4 study on preventing smoking relapse in individuals with schizophrenia or schizoaffective disord…
-
FDA approval · 2016-09-23FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Rexulti (brexpiprazole) from Otsuka America Pharmaceutical, Inc., under NDA 205422.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Phase 1 Safety Study in Adults With Schizophrenia [Phase 1]
A Phase 1 safety study in adults with schizophrenia has completed, providing safety data from an Alkermes-sponsored trial.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia [Phase 3]
This entry reports a Phase 3 clinical trial evaluating minocycline as an add-on to antipsychotics for negative and cognitive symptoms in sch…
-
FDA approval · 2016-09-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
The FDA granted a supplemental approval to Mylan Institutional LLC for haloperidol decanoate, a long-acting injectable antipsychotic. The ac…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia [Phase 2]
Phase 2 clinical trial assessing sarcosine for symptom relief, quality of life, oxidative stress, and glutamatergic measures in schizophreni…
-
FDA approval · 2016-09-12FDA Approved: ARIPIPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved the original ANDA for a generic aripiprazole from Quallent Pharmaceuticals Health LLC. The approval covers a generic versio…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Online Family Support and Education for Schizophrenia [NA]
A completed clinical trial evaluating online family support and education for schizophrenia conducted by UCLA.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Milestones of Adjustment Post-Psychosis [Phase 3]
A Phase 3 clinical trial evaluating milestones of adjustment after psychosis in schizophrenia has been terminated.
-
CLINICAL_TRIALS other · 2016-09-02Clinical Trial Update: Mental Healthcare in Older Adults With Schizophrenia
Clinical trial update focusing on mental healthcare in older adults with schizophrenia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Clinical Study Of Schizophrenia in Both Men and Women [Phase 3]
A Phase 3 clinical study evaluating a schizophrenia treatment sponsored by GlaxoSmithKline has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) [NA]
A completed clinical trial (CapiCor) evaluated the effectiveness of a physical activity and diet program for people with psychotic disorders…